Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindness.
MAbs
; 6(6): 1439-52, 2014.
Article
en En
| MEDLINE
| ID: mdl-25484056
Palabras clave
AA, antibiotic/antimycotic; ALCAM/CD166; CM, conditioned medium; DM, descement membrane; DMEM, Dulbecco's modified Eagle's medium; DSAEK, Descement's stripping automated endothelial keratoplasty; FBS, fetal bovine serum; FGF-2, fibroblast growth factor-2; FNC, fibronectin and collagen-based; FT, flowthrough; GPC-4, Glypican-4; HRP, horseradish peroxidase; ICC, immunocytochemistry; IP, immunoprecipitation; LEC, lens epithelial cells; MACS, magnetic affinity cell separations; MFI, mean fluorescence intensity; MPL, monophosphryl-lipid A; Na+K+ATPase, sodium potassium ATPase; Peroxiredoxin-6; Prdx-6, Peroxiredoxin-6; TDM, trehalose dichorynmycolate; ZO-1, zonula occludins-1; cell enrichment; characterization; hCENC, human corneal endothelial cells; hCSF, human corneal stromal fibroblasts; hPSC, human pluripotent stem cells; human corneal endothelial cells; mAbs, monoclonal antibodies; monoclonal antibodies; nMFI, normalized mean fluorescence intensity
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Endotelio Corneal
/
Ceguera
/
Células Endoteliales
/
Anticuerpos Monoclonales
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
MAbs
Asunto de la revista:
ALERGIA E IMUNOLOGIA
Año:
2014
Tipo del documento:
Article
País de afiliación:
Singapur
Pais de publicación:
Estados Unidos